JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1

Zeuzem, S; Bourgeois, S; Greenbloom, S; Buti, M; Aghemo, A; Lampertico, P; Janczewska, E; Lim, Sg; Moreno, C; Buggisch, P; Tam, E; Corbett, C; Willems, W; Vijgen, L; Fevery, B; Ouwerkerk-Mahadevan, S; Ackaert, O; Beumont, M; Kalmeijer, R; Sinha, R; Biermer, M